샘플 요청 목록

 카트 문의
시장보고서
상품코드
1533986

세계의 이식형 제세동기(ICD) 시장

Implantable Cardioverter Defibrillators (ICD)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 250 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이식형 제세동기(ICD) 시장은 2030년까지 117억 달러에 도달할 것으로 예측됩니다.

2023년 103억 달러로 추정된 이식형 제세동기(ICD) 시장은 2030년에는 117억 달러에 이를 전망이고, 예측 기간 동안 복합 연간 성장률(CAGR)은 1.9%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 경정맥 ICD는 복합 연간 성장률(CAGR) 1.7%로 성장을 지속하고, 분석 기간 종료까지 110억 달러에 달할 것으로 예측됩니다. 피하 OCD 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 5.2%로 추정됩니다.

미국 시장은 28억 달러로 추정, 중국은 복합 연간 성장률(CAGR) 3.9%로 성장할 것으로 예측됩니다.

미국의 이식형 제세동기(ICD) 시장은 2023년 28억 달러로 추정됩니다. 세계의 2위 경제대국인 중국은 2023년부터 2030년의 분석 기간에서 복합 연간 성장률(CAGR) 3.9%로 추이했으며, 2030년에는 시장 규모가 23억 달러에 달할 것으로 예측되고 있습니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 0.4%와 1.3%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 0.8%로 성장할 것으로 예측됩니다.

세계의 이식형 제세동기(ICD) 시장- 주요 동향과 촉진요인 정리

이식형 제세동기(ICD)는 심장 리듬을 모니터링하고 치명적인 부정맥을 수정하기 위해 구명을위한 전기 충격을 제공하도록 설계된 고급 의료기기입니다. 이 장치는 심실 세동과 심실 빈맥에 의해 갑자기 심장 정지를 일으킬 위험이 높은 환자에 이식됩니다. ICD는 심장의 전기적 활동을 지속적으로 모니터링하고 비정상적인 리듬이 감지되면 자동으로 충격을주고 심장 돌연사를 예방합니다. 최신 ICD에는 페이싱 기능도 있어 심각하지 않은 리듬 장애를 관리하는 데 도움이 됩니다. ICD 기술의 진화는 심각한 심장 질환을 가진 환자의 생존과 QOL을 크게 개선하고이 장비를 심장 질환 관리의 핵심으로합니다.

기술의 진보는 ICD의 진화의 중요한 원동력이며, 보다 작고 신뢰성이 높고, 보다 진보된 진단과 치료 개입을 가능하게 하는 기기로 이어지고 있습니다. 경정맥 리드가 필요없는 리드리스 ICD와 같은 기술 혁신은 리드 고장 및 감염과 관련된 합병증을 감소시킵니다. 또한 원격 모니터링 기능의 통합으로 의료 서비스 제공업체는 ICD의 성능과 환자의 심장 리듬을 실시간으로 추적할 수 있어 시기 적절한 의료 개입이 용이해졌습니다. 배터리 기술의 발전으로 ICD의 수명이 연장되고 빈번한 교체가 필요하고 수술의 위험이 줄어듭니다. 또한 고급 알고리즘의 도입으로 부정맥의 검출과 치료의 정확성을 향상시키고 부적절한 충격을 최소화하고 환자의 예후를 개선하고 있습니다.

ICD 시장의 성장은 몇 가지 요인에 의해 발생합니다. 심혈관 질환의 유병률 증가, 특히 노화로 인해 효과적인 부정맥 관리 솔루션에 대한 수요가 증가하고 있습니다. MRI 안전 ICD 개발 및 피하 ICD 등장과 같은 기술 혁신은 이러한 장치를 보다 광범위한 환자에 맞추어 대응 가능한 시장을 확대하고 있습니다. 환자와 의료 종사자들 사이에서 ICD의 장점에 대한 인식과 교육이 증가하고 있는 것도 시장 성장을 뒷받침하고 있습니다. 또한 많은 지역에서 정부의 지원 정책과 보험 상환의 틀이 ICD를 환자에게 더 친숙하게 만듭니다. 의료기기 제조업체와 의료 제공업체와의 전략적 제휴 및 협력 관계도 차세대 ICD의 개발과 보급을 촉진하고 있습니다. 게다가, 개인화된 의료 및 환자에 특화된 치료 계획으로의 흐름은 ICD 치료의 맞춤화와 정확성을 높이고, 그 효과와 매력을 높입니다. 이러한 요인들이 결합되어 이식형 제세동기 시장은 역동적이고 빠르게 확대되고 있습니다.

조사 대상 기업 예(전 86건)

  • Abbott Laboratories
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • EBR Systems, Inc.
  • Element Science, Inc.
  • MEDICO SRL
  • Medtronic Inc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Purple MicroPort Cardiovascular Pvt Ltd
  • ZOLL Medical Corporation;

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.08.26

Global Implantable Cardioverter Defibrillators (ICD) Market to Reach US$11.7 Billion by 2030

The global market for Implantable Cardioverter Defibrillators (ICD) estimated at US$10.3 Billion in the year 2023, is expected to reach US$11.7 Billion by 2030, growing at a CAGR of 1.9% over the analysis period 2023-2030. Transvenous ICD, one of the segments analyzed in the report, is expected to record a 1.7% CAGR and reach US$11.0 Billion by the end of the analysis period. Growth in the Subcutaneous OCD segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 3.9% CAGR

The Implantable Cardioverter Defibrillators (ICD) market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.4% and 1.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.8% CAGR.

Global Implantable Cardioverter Defibrillators (ICD) Market - Key Trends and Drivers Summarized

Implantable Cardioverter Defibrillators (ICDs) are advanced medical devices designed to monitor heart rhythms and deliver life-saving electrical shocks to correct potentially fatal arrhythmias. These devices are implanted in patients who are at high risk of sudden cardiac arrest due to ventricular fibrillation or ventricular tachycardia. ICDs continuously monitor the heart's electrical activity and automatically deliver shocks when abnormal rhythms are detected, thereby preventing sudden cardiac death. Modern ICDs also offer pacing capabilities, which can help manage less severe rhythm disturbances. The evolution of ICD technology has significantly improved survival rates and quality of life for patients with serious cardiac conditions, making these devices a cornerstone in the management of heart disease.

Technological advancements have been a key driver in the evolution of ICDs, leading to devices that are smaller, more reliable, and capable of more sophisticated diagnostics and therapeutic interventions. Innovations such as leadless ICDs, which eliminate the need for transvenous leads, have reduced complications associated with lead failures and infections. Additionally, the integration of remote monitoring capabilities allows healthcare providers to track the performance of ICDs and the heart rhythms of patients in real-time, facilitating timely medical interventions. Advancements in battery technology have extended the lifespan of ICDs, reducing the need for frequent replacements and the associated surgical risks. Furthermore, the incorporation of advanced algorithms has enhanced the precision of arrhythmia detection and therapy, minimizing inappropriate shocks and improving patient outcomes.

The growth in the ICD market is driven by several factors. The rising prevalence of cardiovascular diseases, particularly in aging populations, has increased the demand for effective arrhythmia management solutions. Technological innovations, including the development of MRI-safe ICDs and the advent of subcutaneous ICDs, have expanded the addressable market by making these devices suitable for a broader range of patients. Increasing awareness and education about the benefits of ICDs among patients and healthcare providers are also propelling market growth. Additionally, supportive government policies and reimbursement frameworks in many regions are making ICDs more accessible to patients. Strategic collaborations and partnerships between medical device companies and healthcare providers are fostering the development and adoption of next-generation ICD technologies. Furthermore, the trend towards personalized medicine and patient-specific treatment plans is driving the customization and precision of ICD therapies, enhancing their effectiveness and appeal. Collectively, these factors are contributing to a dynamic and rapidly expanding market for implantable cardioverter defibrillators.

Select Competitors (Total 86 Featured) -

  • Abbott Laboratories
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • EBR Systems,Inc.
  • Element Science, Inc.
  • MEDICO S.R.L.
  • Medtronic Inc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Purple MicroPort Cardiovascular Pvt Ltd
  • ZOLL Medical Corporation;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Implantable Cardioverter Defibrillators (ICD) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Spurs Demand for ICDs
    • Technological Innovations Propel Growth in ICD Adoption
    • Development of MRI-Safe ICDs Expands Addressable Market Opportunity
    • Advancements in Leadless ICD Technology Strengthen Business Case for Newer Devices
    • Integration of Remote Monitoring Capabilities Drives Market Expansion
    • Trend towards Personalized Medicine Drives Adoption of Tailored ICD Therapies
    • Extended Battery Life of ICDs Sustains Growth in Market Demand
    • Rising Geriatric Population Throws the Spotlight on Need for Cardiac Care Solutions
    • Real-Time Data and Advanced Algorithms Enhance Precision and Minimize Inappropriate Shocks
    • Emergence of Subcutaneous ICDs Generates New Market Opportunities
    • Improved Patient Outcomes Strengthen Business Case for ICD Use
    • Here's the Story: Reducing Surgical Risks with Innovative ICD Designs
    • Increasing Healthcare Expenditure in Emerging Markets Drives Adoption
    • Growing Trend of Outpatient Cardiac Monitoring Spurs Demand for Remote ICD Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Implantable Cardioverter Defibrillators (ICD) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transvenous ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Transvenous ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Transvenous ICD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Subcutaneous OCD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Subcutaneous OCD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Subcutaneous OCD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Single-Chamber ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Single-Chamber ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Single-Chamber ICDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Dual-Chamber ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Dual-Chamber ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Dual-Chamber ICDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biventricular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biventricular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Biventricular Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제